Literature DB >> 21234017

Knowledge and Attitudes of Physicians about Lipids.

N Macdonald, B Daub.   

Abstract

A sample of 323 physicians from Edmonton, Alberta, was surveyed to evaluate their attitudes and knowledge level concerning heart disease and lipids. Of the sample, 117 physicians returned the questionnaire. When asked to choose significant risk factors of cardiovascular disease, 69% of the physicians indicated hypertension; 85% indicated smoking; and 87% indicated elevated serum cholesterol. Concerning the minimal low-density lipoprotein level that warrants treatment, 82% of the general practitioners and 50% of the specialists indicated that 4.2 mmol/L was the minimal level. This is in contrast to the level of 3.4 mmol/L for low-density lipoprotein recommended by the Canadian Consensus Conference on Cholesterol as the level at which treatment should be initiated.

Entities:  

Year:  1990        PMID: 21234017      PMCID: PMC2280560     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

Review 1.  Consensus reports: implications for the management of hypercholesterolemia and for future research.

Authors:  J A Little; L Horlick
Journal:  CMAJ       Date:  1989-02-15       Impact factor: 8.262

Review 2.  Cholesterol and coronary heart disease. A new era.

Authors:  S M Grundy
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

3.  Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial.

Authors:  W B Kannel; J D Neaton; D Wentworth; H E Thomas; J Stamler; S B Hulley; M O Kjelsberg
Journal:  Am Heart J       Date:  1986-10       Impact factor: 4.749

Review 4.  Reducing cardiac deaths with hypolipidemic drugs.

Authors:  H K Naito
Journal:  Postgrad Med       Date:  1987-11-01       Impact factor: 3.840

5.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

6.  Change in physician perspective on cholesterol and heart disease. Results from two national surveys.

Authors:  B Schucker; J T Wittes; J A Cutler; K Bailey; D R Mackintosh; D J Gordon; C M Haines; M E Mattson; R S Goor; B M Rifkind
Journal:  JAMA       Date:  1987-12-25       Impact factor: 56.272

7.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

8.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors:  V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

Review 9.  Management of lipids in primary and secondary prevention of cardiovascular diseases.

Authors:  C J Lavie; G T Gau; R W Squires; B A Kottke
Journal:  Mayo Clin Proc       Date:  1988-06       Impact factor: 7.616

10.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

View more
  1 in total

1.  Prevention in family practice: Consensus statement from the front line.

Authors:  G Satenstein; J Lemelin; C Folkerson; K A Scott; W E Hogg
Journal:  Can Fam Physician       Date:  1991-10       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.